ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

October 29, 1999

Release of Mayo Pathology Report Would Be Needed To Confirm Stage IIA Diagnosis.

October 24, 2008

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985